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Abstract
Background Radiosurgery by Gamma Knife (GK) is an effec-
tive treatment for brain arteriovenous malformations (AVM).
The aim of the present study was to evaluate late, radiation-
induced changes detectable by MRI after AVM radiosurgery
in patients treated minimally 10 years prior, with AVM oblit-
eration proven by angiography.
Methods Thirty-five patients with 37 AVMs were included.
AVMs were irradiated 16.6 ± 3.5 years prior with AVM oblit-
eration proven 13 ± 4 years prior. All patients underwent re-
cent MRI examinations, including application of gadolinium-
based contrast.
Results In one case, post-irradiative cystic formation with mass
effect andsignsofhemorrhage requiringsurgerywas found.Post-
gadolinium enhancement at the site of obliterated nidi was
apparent in 28 of 37 cases (76 %). In all cases except one,
the mean volume of enhancement at the time of review
was clearly lower than the volume of the originally irra-
diated AVM (88 ± 20 %; median 92 %); in one case the
extent was 142 % greater than the irradiated AVM. When
we compared enhancing and non-enhancing nidi, we
found that enhancing nidi were significantly larger than
non-enhancing nidi at the time of radiosurgery (4.39 ±
3.35 cc vs. 0.89 ± 0.79 cc, p = 0.004). Enhancement
was not influenced by total radiation dose, patient age at
the time of irradiation, duration since radiosurgery, or the
number of irradiations. Wallerian degeneration was found in
nine of 37 cases (24 %); in six cases the optical tracts were
affected and visual field defects were proven. In five of nine
cases (55.6 %) with Wallerian degeneration previous hemor-
rhage was present. Dual vascular pathology was found in eight
of 35 patients (23 %).
Conclusions GK radiosurgery for AVM is a safe treatment
method although delayed complications may occur. Post-
gadolinium enhancement of obliterated nidi may indicate an
active post-irradiative process.
Keywords Gadolinium enhancement .Wallerian
degeneration . Cyst formation . Post-irradiation
Introduction
Arteriovenous malformations (AVM) in the brain are charac-
terized by a conglomerate of tortuous vessels with feeding
arteries and draining veins. These vessels shunt directly from
the arterial to the venous system; normal intervening capillary
networks are absent. Additionally, the endothelial cell layer in
AVMs structurally differs from normal cerebrovascular
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endothelium [1]. Hemorrhage associated with AVM is the
most significant cause of morbidity and mortality. Treatment
for AVM includes surgery, radiosurgery, or embolization
alone or in combination. Radiosurgery by Gamma Knife
(GK) has been proven an effective treatment for AVM [2–6].
We have provided stereotactic radiosurgery for the treat-
ment of AVM at our institution since 1992. We use digital
subtraction angiography (DSA) and magnetic resonance im-
aging (MRI) for the stereotactic localization of AVMs. First
MRI follow–up is standardly performed 2 years after radio-
surgery. After the disappearance of flow voids on MRI, DSA
is indicated to prove complete AVM obliteration. In the case
of suspected complication, computed tomography (CT) or
MRI is performed to exclude re-bleeding or postirradiation
edema. Once complete obliteration of the AVM is verified
by DSA, only symptomatic patients continue to be followed
actively at our institution.
It has previously been reported that AVM obliteration was
achieved in 74 % patients after the first round of radiosurgery
and in 69 % of remaining patients after a second round of
radiosurgery [6]. The overall chance of cure was 92 % [6].
The risk of re-bleeding after radiosurgery has been reported as
2.1 % annually until full obliteration and the overall mortality
from re-bleeding as 1 %, with cumulative morbidity risk at
3.4 % [6].
Although stereotactic radiosurgical treatment for AVM is a
well-established method, delayed, long-term postirradiative
changes onMRI after GK treatment have not been sufficiently
investigated. In the present study, we evaluated late radiation-
induced changes on MRI following radiosurgical AVM treat-
ment in a group of patients treated between the years of 1993
and 2005 in whom complete AVM obliteration was proven by
DSA, with no symptomatic complications since.
Materials and methods
Patient selection
We examined all available medical records of patients treated
by GK radiosurgery for AVM between the years 1993 and
2005. In this period, 675 patients were identified. They came
from the region of former Czechoslovakia and also abroad.
Only patients living in the vicinity of our facility were selected
for accessibility purposes. We further excluded all patients
who underwent open surgery following GK radiosurgery
failure, as well as patients with severe disabilities, preg-
nant or lactating women, and patients older than 70 years.
One hundred and eight patients were contacted by phone
or by mail and offered a follow-up MRI examination with
gadolinium-based contrast. The study was approved by
the local ethics committee and all participants provided
written informed consent.
Summary of the inclusion criteria:
1. Patients that underwent their first radiosurgical procedure
for AVM between the years 1993 and 2005 (minimally
10 years prior to the present study) by Leksell Gamma
Knife (Elekta Instruments AB, Stockholm, Sweden).
Patients that underwent a second or third radiosurgical
procedure 3 years after the first procedure due to patent
AVM were also included.
2. Complete obliteration of the AVM proven by DSA.
3. Age under 70 years, not pregnant, not lactating, and in
good health.
4. No contraindications to MRI.
MRI methods
All patients underwent MRI examinations. MRI was per-
formed using a 3T whole-body MRI scanner (Magnetom
Skyra, Siemens, Erlangen, Germany) fitted with a 32-
channel head coil. The MRI protocol included the following
sequences and parameters:
& TSE T2 / PD t r a n s v e r s a l s c a n s ( v o x e l s i z e
0.3 × 0.3 × 0.4 mm, slices 27, distance factor 30 %, slice
thickness 4 mm, TR 3600 ms, TE 9.4 ms, averages 1,
concatenations 1, flip angle 160°)
& FLAIR FAT-SAT transversal scans (voxel size
0.7 × 0.7 × 3.5 mm, slices 36, distance factor 20 %, slice
thickness 3.5 mm, TR 8500 ms, TE 81 ms, averages 1,
concatenations 2, TI 2439 ms, flip angle 150°)
& T2 SWI 3D t r a n s v e r s a l s c a n s ( v ox e l s i z e
0.5 × 0.5 × 2.5 mm, slabs 1, slices per slab 64, distance
factor 20 %, slice thickness 2.5 mm, TR 27 ms, TE 20 ms,
averages 1, concatenations 1, flip angle 15°)
& GE T1 coronal and transversal scans (voxel size
1.0 × 1.0 × 3.0 mm, slices 22, distance factor 0 %, slice
thickness 3 mm, TR 3 ms, TE 168 ms, averages 3, con-
catenations 2, flip angle 50°)
& SE T1 sagittal scans (voxel size 0.4 × 0.4 × 4.0 mm, slices
25, distance factor 30 %, slice thickness 4 mm, TR
650 ms, TE 8.2 ms, averages 2, concatenations 1, flip
angle 50°)
& DWI FAT-SAT transversal scans (voxel size 0.6 × 0.6 × 4
mm, slices 25, distance factor 30 %, slice thickness 4 mm,
TR 6400 ms, TE 98 ms, averages 3, concatenations 1,
diffusion weightings 2, b = 0, b = 1000, ADC maps)
& GE T1 3D after gadolinium intravenous administration
(voxel size 0.7 × 0.7 × 0.7 mm, slabs 1, slices per slab
240, distance factor 50 %, slice thickness 0.7 mm, TR
1820 ms, TE 2.37 ms, averages 2, concatenations 1, TI
1070 ms, flip angle 6°).
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Volumetry of the enhancing AVM nidus was performed,
when present. Volumes were segmented manually and calcu-
lated with software developed on in-house for a standard work
console.
The defined endpoints of interest were as follows:
A. In–field changes (in the field of radiosurgery)
& Cyst formation was considered relevant in cases
where minimally one of the following was present:
mass effect, high protein content, perifocal vasogenic
edema, cyst wall enhancement. Post-hemorrhagic
pseudocystic changes with cerebrospinal fluid con-
tent, without enhancement and without mass effect
were considered as insignificant post-hemorrhagic
changes.
& Presence of post-gadolinium AVM nidus enhance-
ment including volumetry.
B. Out-of-field changes
& Presence of Wallerian degeneration due to irradiation
or complication of hemorrhagic AVM.
C. Dual pathology elsewhere
& Presence of vascular or other dual pathology onMRI.
Statistics
Data were expressed as mean ± SD in variables with
Gaussian distribution and as median. We analyzed various
potential effects on post-gadolinium nidus enhancement
by means of unpaired t tests; categorical values were analyzed
using the Chi-square test; p values 0.05 were considered sig-
nificant. Analyses were performed using STATISTICA soft-
ware, vers. 12.
Results
Patient selection
The patient response rate was 32.4 %. Thirty-five patients (14
male, 21 female) met the inclusion criteria and were included
in the study; mean age of included subjects was 49.4 ±
12.4 years (median, 46 years). The AVMs were irradiated
16.6 ± 3.5 years (median, 17 years, range, 10–22 years) prior;
AVM obliteration proven by DSA performed 13 ± 4 years
(median, 13 years, range, 4–21 years) prior. Thirty-seven
AVM nidi in 35 subjects were irradiated (two patients with
two AVMs). AVMs were graded according to the Spetzler–
Martin AVM classification [7] as Grade I in five, Grade II in
21, Grade III in eight, and Grade IV in three cases. The mean
volume of the irradiated nidi was 3.41 ± 3.27 cc (median,
2.60 cc). Eleven AVM nidi were irradiated twice and 1
AVM was irradiated three times. The maximum dose of
the first irradiation was 43.5 ± 7 Gy (median, 44 Gy,
range, 34–54 Gy) with a margin dose of 21.7 ± 3.6 Gy
(median, 22 Gy, range, 17–27 Gy). Eleven AVMs were
secondarily irradiated with a maximum dose of 38.5 ± 7 Gy
(median, 40Gy, range, 28–46Gy) and amargin dose of 19.2 ±
3.5 Gy (median, 20 Gy, range, 15–25 Gy). One AVM was
irradiated a third time by a maximum dose of 44 Gy and a
margin dose of 22 Gy.
MRI data
Only one (of 37 irradiated nidi; 2.7 %) serious late com-
plication requiring urgent surgery was found on MRI; it
was a post-irradiation cyst formation with mass effect and
signs of hemorrhage. For more details, see the case report
below.
We found next 12 pseudocysts with hemosiderin rim
surrounded by gliosis, with cerebrospinal fluid content.
Eleven of those pseudocysts were present on MRI before
GK treatment; all those AVMs manifested as intracranial
bleeding. In one patient, clinical symptomatic bleeding was
present 1 year after irradiation, since that time pseudocystic
changes were present. Those cases were considered as irrele-
vant post-hemorrhagic pseudocystic changes.
Post-gadolinium enhancement of the obliterated AVM ni-
dus site was apparent in 28 of 37 cases (76 %). In only nine of
37 (24 %) cases, enhancement of the AVM nidus site was not
detectable after intravenous contrast administration. In all
cases except one, the mean volume of enhancement was clear-
ly lower than the volume of the irradiated AVM. The extent of
enhancement was approximately 88 ± 20 % (median 92 %)
less than the volume of originally irradiated nidus. In one case,
the extent of enhancement was clearly greater than the irradi-
ated nidus (roughly 142 %) and was surrounded by irregular
deposits of hemosiderin, although the patient did not suffer
from hemorrhage before radiosurgery or at time of the last
MRI follow-up 15 years prior. The MRI appearance in this
case resembled cavernous malformation (Fig. 1).
Enhancing nidi were significantly larger than non-
enhancing nidi at the time of irradiation (4.39 ± 3.35 vs.
0.89 ± 0.79 cc, p = 0.004). For more details, see Table 1.
Post-gadolinium enhancement was not influenced by any of
the following: total radiation dose, patient age at the time of
irradiation, time delay since GK radiosurgery. When we com-
pared subgroups, AVM nidi irradiated once versus nidi irradi-
ated more than once (two or three times), we did not find any
statistically significant differences in proportion of enhance-
ment: 17 of 25 (68 %) AVM nidi irradiated once and 10 of 11
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(91 %) nidi irradiated more than once enhanced after gadolin-
ium administration (p = 0.14, Chi-square test).
Table 1 also documents that AVMs with nidi larger than
5.00 cc were only occasionally associated with hemorrhage.
These nidi manifested with intracranial bleeding in 12.5 % of
cases; significantly less (p = 0.04) than nidi smaller than
5.00 cc, in which hemorrhage prior to radiosurgery was de-
tected in 54.2 % (see Table 1 for comparison of AVM-
associated hemorrhage before radiosurgery in relation to
AVM nidus volume).
Wallerian degeneration was found in nine of 37 cases
(24 %). In six cases, the optical tracts were affected (in four
cases AVMs were situated in the temporal lobes, in two cases
in temporo-occipital regions). In one case, the pyramidal tract
was degenerated (AVM was situated in the centrum
semiovale; Fig. 2) and in one case Wallerian degeneration
affected the external capsule and corpus callosum. In all pa-
tients with signs of Wallerian degeneration of the optical
tracts, visual field defects were proven. In five of nine cases
(55.6 %), previous hemorrhage before treatment was present.
For more details, see Table 2.
No dual pathology was located in the field of radiosurgery.
With the exception of two patients who suffered dual AVM,
vascular dual pathology was present in eight of 35 patients
(23 %); in four subjects arterial aneurysms, in two subjects
cavernous malformations, and in two patients venous angio-
mas were detected. Non-vascular dual pathology was detected
in two patients (low-grade glioma in one patient and multiple
metastases from breast carcinoma in one patient). Multiple
metastases were found at time of the late review and the pa-
tient was immediately sent for oncological treatment. In the
second case, the presence of low-grade glioma was known
since the time of AVM diagnosis. The patient was sent for
MRI after the first generalized epileptic seizure; AVM in the
left occipital lobe and low-grade glioma in the right frontal
lobe was found. In the same year, the patient underwent neu-
rosurgical resection of the glioma and radiosurgery for the
AVM. At time of the late review, the patient was asymptom-
atic (for more details, see Table 2).
Case report
Twenty-one years ago, a 60-year-old man underwent radio-
surgery for an AVM in the right frontal lobe, which manifested
with intracerebral hemorrhage. The size of the nidus was
12 × 24 × 13 mm (nidus volume was 1.95 cc), and the AVM
was irradiated by a maximum dose of 50 Gy with a marginal
dose of 25 Gy. One year later, DSA follow-up showed com-
plete obliteration of the AVM. The patient did not suffer from
any clinical manifestations and therefore follow-up at our in-
stitution was terminated; he was advised to continue follow-
up with his local neurologist. Twenty years later, he agreed to
participate in the present study. MRI revealed cystic changes
measuring 44 × 51 × 39 mm in the right frontal region, with
defiguration of the frontal horn of the right lateral ventricle
Fig. 1 MRI appearance of the
cavernous malformation-like
lesion. AVM was irradiated
18 years prior; at the time of irra-
diation, the AVM nidus was
0.71 cc, AVM obliteration was
proven 3 years later. There were
no signs of hemorrhage. Recent
MRI showed extended hemosid-
erin deposition and
post-gadolinium enhancement
covering a larger area than the
AVM. (Upper left: TSE T2 trans-
versal scan, upper right: SE T1
sagittal scan, lower left: T2 SWI
3D transversal scan, lower right:
GE T1 3D post-gadolinium
transversal scan)
Table 1 Post-gadolinium enhancement of AVM nidi
Volumes of
irradiated nidi
(cc)
Presence of
post-gadolinium
enhancement
Presence of clinically
significant or MRI
detectable hemorrhage
before AVM occlusion
>10.00 100 % 0 %
5.00–10.00 100 % 17 %
1.00–5.00 85.7 % 64 %
<1.00 30 % 50 %
AVM arteriovenous malformation, MRI magnetic resonance imaging
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and slight midline shift. Signs of repeated hemorrhage with
fluid–fluid level were observed (Fig. 3). After intravenous
contrast administration, the wall of the cyst and the previously
irradiated AVM nidus clearly enhanced (Fig. 4). Neurologic
examination revealed only prefrontal psychological changes.
The patient was informed that surgery was needed and pro-
vided consent. Two weeks later, he was admitted to our hos-
pital following a secondary generalized epileptic seizure
(negative history) with subsequent prolonged uncon-
sciousness, for which he was intubated. CT showed cyst
formation detected previously on MRI, DSA proved AVM
occlusion. After extubation, four electrographic seizures
originating in right prefrontal leads were found on routine
20-min EEG. Interictally, bifrontal nonspecific abnormal-
ities with left preponderance were present. Antiepileptic
drugs (phenytoin, clonazepam) were introduced. On
subsequent neurologic examination, prefrontal psycholog-
ical changes were again found. Urgent surgery was indi-
cated. A small frontal craniotomy via right supraorbital
incision was performed. Linear incision of the dura was
followed by microsurgical resection of the MRI enhancing
lesion located superficially. The lesion had a fibrotic consis-
tency and several small vessels were seen on its surface. These
vessels tightly adherent to the cyst were coagulated and cut.
During the resection of the enhancing lesion, the cyst was
entered and a yellowish liquid was drained. Communication
with the ventricle appeared spontaneously and the ostium was
dilated deliberately. Surgery was proceeded by hemostasis and
dural watertight suturing. The bone flap was fixed by a titani-
um plate and the soft tissue was sutured in layers. Histological
Table 2 Summary of MRI findings
AVM
without pre-treatment hemorrhage
AVM with pre-treatment hemorrhage
No. of nidi 19 18
Clinically relevant cyst formation 0 1
Wallerian degeneration Optical tract 2 4
Pyramidal tract 1
Corpus callosum 1
External capsule 1
Cavernous malformation-like MRI appearance 1 0
Delayed nidus enhancement 14 14
Vascular dual pathology Cavernous malformation in 1 pt;
Multiple venous angiomas in 1 pt
Multiple cavernous malformations in 1 pt;
Arterial aneurysms in 4 pts;
Venous angioma in 1 pt
Non-vascular dual pathology LGG in 1 pt Multiple metastases in 1 pt
MRI magnetic resonance imaging, LGG low-grade glioma
Fig. 2 Wallerian degeneration of the right pyramidal tract. The irradiated
AVM was situated in the right centrum semiovale. The degenerated
pyramidal tract is depicted by the white arrow (TSE T2 coronal scan)
Fig. 3 Cyst formation in the right frontal lobe (non-contrast scan). There
are clear signs of mass effect, high protein cyst content, and fluid–fluid
level (FLAIR transversal scan)
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examination of the resected sample revealed AVM with oc-
cluded channels, channels with recanalization, and signs of
neoangiogenesis (Fig. 5). Surrounding gliosis was remark-
able. In the vessel walls, deposition of ferric compounds was
detected (Fig. 6).
Discussion
Radiosurgery is a very successful minimally invasive treat-
ment for brain AVM, with AVM obliteration occurring in
more than in 90 % of treated cases [6]. The disadvantage of
this method is the risk of re-bleeding until complete oblitera-
tion, as well as possible acute and subacute complications of
GK treatment such as postirradiative edema [6]. However,
there is also risk of delayed complications due to radiosurgical
injury [8]. Radiation injury depends on numerous factors, of
which the dose and the volume of irradiated tissue are the most
important [9]. However, it is well known that the degree of
radiographic changes is extremely variable and unpredictable
[10]. It is influenced by the type of tissue treated, by the loca-
tion of the lesion, as well as by individual sensitivity to
radiation injury. It is widely accepted that normal brain tissue
is more vulnerable to radiation injury than brain tumors [11].
In the present study, 35 patients (with 37 AVMs) were
included who were treated by radiosurgery 16.6 ± 3.5 years
prior to study onset, with AVM obliteration proven 13 ±
4 years prior. We found only one case (2.7 %) of serious late
post-irradiative complication; a large cystic mass with high
protein content and an enhancing wall. This patient required
open surgery. Cyst formation is a rare but well-documented
complication following radiosurgery for AVM [12, 13]. Its
prevalence varies according to published reports from 1.1 %
[14] to 5.5 % [13]. The prevalence of cyst formation may be
higher in unruptured AVMs, as normal perinidal brain paren-
chyma is more vulnerable to radiation than gliosis after hem-
orrhage [14]. However, in the present case, symptomatic
bleeding was present before GK radiosurgery. In a previous
study by Izawa et al., predisposing factors for cyst formation
included a large nidus volume, a high maximum dose, lobar
localization, and complete AVM obliteration [15]. Delay from
radiosurgery to cystic formation ranged from several months
to many years. In the present case, GK radiosurgery was per-
formed 21 years prior and AVM obliteration was proven
20 years prior to the study.
Fig. 4 Cyst formation in the right
frontal lobe (post-gadolinium
scan). Nodular irregular
enhancement in the wall of
the cystic formation is present
(GE T1 3D post-gadolinium
transversal and sagittal scans)
Fig. 5 Histology sample 1. AVM with occluded channels and channels
with signs of recanalization and neoangiogenesis; surrounding gliosis is
also remarkable (Masson trichrome – elastica, magnification 40×)
Fig. 6 Histology sample 2. Deposition of ferric compounds were
detected in blood vessel walls (Prussian Blue, magnification 100×)
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According to previous reports, there are two types of
cystic formations: chronic encapsulated expanding hema-
toma, and cysts with a neo-angiogenetic nodule in their
wall. Common etiological mechanisms have been sug-
gested for both types of lesions [16]. The development
of cystic changes may occur in several steps: inflamma-
tion of the perinidal parenchyma; blood–brain barrier
damage due to inflammation; formation of dilated capil-
lary vessels with damaged walls; serum protein exudation
with subsequent development of a perinidal cavity; neovascu-
larization in the wall of this cavity with neo-angiogenetic nod-
ule formation; repeated hemorrhage from fragile vessels into
the cavity leading to osmotic cyst expansion or chronic encap-
sulated hematomas.
In the present study, we found that most obliterated nidi (28
of 37 nidi; 76 %) still clearly enhanced after intravenous gad-
olinium contrast administration, 16.6 ± 3.5 years after GK
radiosurgery. This is in agreement with a similar study con-
ducted by Kihlstrom et al., where 61 % of obliterated nidi
enhanced after contrast administration [17]. They examined
18 patients with AVMs, who were treated with GK and in
whom MRI was obtained a mean of 14 years after treatment
and 10 years after confirmed AVM obliteration [17].
Postgadolinium enhancement in the site of AVM nidus is ex-
plainable by histological findings that were gained in a surgi-
cally treated patient who was discussed above. Histological
evaluations showed signs of AVM vascular channel recanali-
zation. This may explain the enhancement detected in the
AVM nidus site, however it does not indicate the presence
of an arteriovenous shunt, which was clearly excluded by
DSA. Histology also showed newly formed vascular
structures with iron deposits in their walls. These findings
correspond with neo-angiogenesis and damage to the
walls of newly formed vessels. Vascular injury, damage
to the blood–brain barrier, vasogenic edema, and neo-
angiogenesis are well-known effects of radiosurgery.
Neovascularization has been described after radiosurgery
for cavernous malformations [18] as well as radiosurgery
in hippocampal sclerosis [8].
When we compared enhancing and non-enhancing ni-
di, we found that later enhancing nidi were significantly
larger than non-enhancing at time of radiosurgery (4.39 ±
3.35 cc vs. 0.88 ± 0.79 cc, p = 0.004). However, en-
hancement was not influenced by total radiation dose,
patient age, or duration since GK radiosurgery. We also
did not find any statistical differences between
postgadolinium nidi enhancement in subgroups AVM ni-
di irradiated once and more than once (two or three
times). We found that nidi larger than 5.00 cc were as-
sociated with significantly less pre-treatment hemorrhage
(12.5 % nidi) as opposed to nidi smaller than 5.00 cc
(54.2 %). Similar findings have been described previous-
ly [6, 19, 20].
We detected Wallerian degeneration in nine of 37 cases
(24 %). Typically, the optical tracts were affected in cases
where the irradiated AVM was situated in temporal or
occipital lobes. These patients suffered from visual field
defects. Wallerian degeneration is a complication of GK
radiosurgery that has received little attention previously
[21]. However, in the case of AVM, Wallerian degenera-
tion may also by partly or fully caused by previous hem-
orrhage. Fifty-five percent of subjects with signs of
Wallerian degeneration had hemorrhage as a manifestation
of AVM.
Our study has several important limitations. First, not
all patients treated between the years 1993 and 2002
could be evaluated; the patient response rate was only
32 %. Most patients were lost to follow-up while only
some refused to participate in the study. Due to the low
response rate, it is difficult to assess sensitivity of the
MRI findings. We could speculate that the low response
rate may be partially due to good medical condition of the
patients or on the contrary due to bad health. Some pa-
tients probably died. Also, in some older cases, medical
documentation was not complete. We included patients
irradiated only once, as well as those who underwent 2–
3 irradiations. This approach may have resulted in some
bias. However, we did not observe significant differences
in the proportion of postgadolinium enhancement between
these two subgroups.
In conclusion, GK radiosurgery for AVM is a safe treat-
ment method, although delayed complications cannot be
avoided and were found 16.6 ± 3.5 years after therapy.
Additionally, post-gadolinium enhancement could be a sign
of an active, delayed post-irradiative process.
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